Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alzheimer Dementia: early-phase trial registry
5 of 9 indexed Alzheimer Dementia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Alzheimer Dementia: 9 US clinical trials tracked, 5 recruiting.
Alzheimer Dementia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Brent Forester, running 1 of these trials.
Enrollment posture brief
Registry condition alzheimer-dementia
OPEN 5 | RECR 56% | LATE 0 | EARLY 3 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)
Alzheimer Dementia lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alzheimer Dementia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alzheimer Dementia is recruiting above its size-band peers.
5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Alzheimer Dementia trials is spread across many organizations.
Brent Forester accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Alzheimer Dementia trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 9 trials that report a genuine target (sentinel values excluded). 8 of those (88.9%) plan for fewer than 100 participants.
-
Alzheimer Dementia research is mostly interventional.
9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
University of Arizona
NCT04838301
Treating Hyperexcitability in AD With Levetiracetam
Beth Israel Deaconess Medical Center
NCT03875638
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
Brent Forester
NCT03926520
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Covenant Health, US
NCT07222280
Innate Immunity Stimulation Via TLR9 in Early AD
NYU Langone Health
NCT05606341
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
Massachusetts Institute of Technology
NCT04055376
Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease
Hebrew SeniorLife
NCT04289402
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
University of North Carolina, Chapel Hill
NCT04058886
The Senior Companion Program Plus
The University of Texas at Arlington
NCT03602391
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Alzheimer Dementia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alzheimer Dementia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alzheimer Dementia page
9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Alzheimer Dementia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Brent Forester sponsors the most Alzheimer Dementia trials on record, review their full trial history before evaluating a specific study. See Brent Forester's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alzheimer Dementia condition card totals 9 registered trials; most-linked intervention SCP Plus; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.